Skip to content

Insider · CIK 0001982730

Paul Gisbert Auwaerter

director

Files at CAPR (CAPRICOR THERAPEUTICS, INC.). First filing -, latest -.

In brief

Paul Gisbert Auwaerter files SEC Form 4 as director at CAPR (CAPRICOR THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Paul Gisbert Auwaerter has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 6 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 5, 2026CAPR
CAPRICOR THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+15,500$0.00$015,500Jan 7, 2026
Jan 5, 2026CAPR
CAPRICOR THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+1,360$0.00$01,360Jan 7, 2026
Jan 5, 2026CAPR
CAPRICOR THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+5,420$0.00$05,420Jan 7, 2026
Jan 2, 2025CAPR
CAPRICOR THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+11,940$0.00$011,940Jan 6, 2025
Jan 2, 2025CAPR
CAPRICOR THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+1,440$0.00$01,440Jan 6, 2025
Jan 2, 2025CAPR
CAPRICOR THERAPEUTICS, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+5,750$0.00$05,750Jan 6, 2025

Questions about Paul Gisbert Auwaerter

Answered from the filings on this page, as of the latest one.

Is Paul Gisbert Auwaerter buying or selling?

Paul Gisbert Auwaerter has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Paul Gisbert Auwaerter's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Gisbert Auwaerter has 0.

Where does Paul Gisbert Auwaerter file Form 4?

Paul Gisbert Auwaerter has filed Form 4 at CAPR (CAPRICOR THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Paul Gisbert Auwaerter: insider trades and track record | InsiderTell